USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
European Clinical Laboratory Services Growth Opportunity
Customer Experience Driven by New B2B and B2C Business Models
01-Mar-2022
Europe
Market Research
K720-01-00-00-00
HC03514-EU-MT_26320
$2,450.00
Special Price $1,837.50 save 25 %
Diagnostics is the backbone of the healthcare sector. According to a World Health Organization (WHO) study, although the segment accounts for less than 5% of hospital costs, its findings influence 60–70% of healthcare decision-making. Diagnostics helps to analyze medical conditions and guide patients toward the right medication, treatment, or surgery. The COVID-19 pandemic has underscored and redefined the significance of clinical laboratories. Working largely unseen, laboratories are a vital link in the chain of activities required to keep populations safe from diseases. In recognition of this, the WHO and the European Centre for Disease Prevention and Control (ECDC) moved quickly following the identification of the virus on 7 January 2020 to identify laboratory needs and capacities in Europe.
Molecular testing stepped up to meet the additional demand for insights in diagnostics, life science research, pharmaceutical R&D, and public safety. Molecular diagnostics is expanding to new areas of medicine and is enabling clinicians to monitor cancer, infectious disease, immune status, and pre-natal and neo-natal health. The migration of genomic technologies from basic research into the mainstream will remain a powerful driver for long-term industry growth and will boost the need for scalable and efficient user-friendly workflows in molecular testing.
Labs will have to provide comprehensive IVD solutions and cover clinical chemistry and immunoassays, molecular and digital diagnostics, POCT, patient self-testing, next-generation sequencing, laboratory automation and IT, and decision support, where half or more of the population has private coverage. Value-based healthcare (VBHC) is increasingly used in public discourse and, often, value is discussed as health outcomes relative to the monetized input. No singular definition of value exists in the VBHC space; the definition is subjective, and what is considered valuable can differ across patients, clinicians, healthcare providers, policymakers, and industry stakeholders.
Author: Tejashri Khadilkar
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the European Clinical Laboratory Services Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Market Segmentation
Opportunity and Threat Analysis
Opportunity and Threat Analysis (continued)
Key Trends
Key Trends (continued)
Key Trends (continued)
Growth Drivers
Growth Drivers (continued)
Growth Drivers (continued)
Growth Restraints
Growth Restraints (continued)
Growth Restraints (continued)
Market Highlights
COVID-19 Impact on Clinical Testing Services and Healthcare Diagnostics
European Clinical Laboratory Services Market—Highlights
EU5 Clinical Laboratory Services Market—Highlights
EU5 Clinical Laboratory Services Market—Highlights (continued)
European Clinical Laboratory Services Market—Highlights
Competitor Landscape*
Labcorp (Independent Reference Laboratory)
Quest Diagnostics (Independent Reference Laboratory)
Sonic Healthcare (Independent Reference Laboratory)
Eurofins Scientific (Independent Reference Laboratory)
Synlab International GmbH (Independent Reference Laboratory)
Myriad Genetics, Inc. (Independent Speciality Laboratory)
Centogene—The Rare Disease Company (Independent Speciality Laboratory)
Freiburg University Hospital (Hospital-based Laboratory)
Medicover Hospital (Hospital-based Laboratory)
Holistic Business Model—Laboratories as One-stop Shop Service Providers
Cross-sectoral Partnerships
Growth Opportunity 1—Increased Support for Europe’s Beating Cancer Plan for Improved Early Detection, Treatment, and Care
Growth Opportunity 1—Increased Support for Europe’s Beating Cancer Plan for Improved Early Detection, Treatment, and Care (continued)
Growth Opportunity 2—On-demand Digital Diagnostic Services for Improved Access and Personalized Healthcare
Growth Opportunity 2—On-demand Digital Diagnostic Services for Improved Access and Personalized Healthcare (continued)
Growth Opportunity 3—Advance Diagnostic Excellence for a Superior Patient and Clinician Experience
Growth Opportunity 3—Advance Diagnostic Excellence for a Superior Patient and Clinician Experience (continued)
Growth Opportunity 4—Transition to AI and Digital Pathology for Efficient Multisite Operations
Growth Opportunity 4—Transition to AI and Digital Pathology for Efficient Multisite Operations (continued)
Conclusions
Bibliography
Bibliography (continued)
List of Exhibits
Legal Disclaimer
List of Figures
- Clinical Laboratory Services: Growth Drivers, Europe, 2021–2026
- Clinical Laboratory Services: Growth Restraints, Europe, 2021–2026
- Impact of COVID-19 on Clinical Laboratories and Allied Healthcare Participants, Global, 2021
- Clinical Laboratory Services Market: B2B and B2C Models by Services and End Users, Europe, 2020
- Clinical Laboratory Services Market: B2B and B2C Models by Services and End Users, Europe, 2020
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| List of Charts and Figures | Clinical Laboratory Services: Growth Drivers, Europe, 2021–2026~ Clinical Laboratory Services: Growth Restraints, Europe, 2021–2026~ Impact of COVID-19 on Clinical Laboratories and Allied Healthcare Participants, Global, 2021~ Clinical Laboratory Services Market: B2B and B2C Models by Services and End Users, Europe, 2020~ Clinical Laboratory Services Market: B2B and B2C Models by Services and End Users, Europe, 2020~ |
| Author | Tejashri Manish Khadilkar |
| Industries | Healthcare |
| WIP Number | K720-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9573-B1,9627-B1 |